Skip to main content
. 2021 Jul 29;37(4):302–314. doi: 10.1159/000517328

Table 6.

Outcomes after LT for neuroendocrine liver metastases

Author Patients, n Criteria for LT RR, % RFS, % OS rate, %
Korda et al. [62] 10 Not specified Median 33 months 50 1/5 years 80/43 1/5 years 89/71

Ruzzenente et al. [63] 28 Milan criteria 5 years 83

Vaivi et al. [61] 206 Not specified Median 28 (1–192) months 34 1/3/5/10 years 89.1/75.3/64.9/46.1

LT, liver transplantation; RR, recurrence rate; RFS, recurrence-free survival; OS, overall survival.